New Non-Hazardous Viral Inactivation Medium Supports Safe Collection and Transport of SARS-CoV-2

Key Facts

• March 08, 2022 03:00 AM Eastern Standard Time BASINGSTOKE, England--(BUSINESS WIRE)--A new viral transport medium that enables collection and rapid inactivation of the SARS-CoV-2 virus, and stabilizes viral RNA at ambient temperature for transportation and use in in vitro diagnostic testing procedures, is now available in Europe.

• “As testing demands continue to change dynamically throughout this pandemic, we remain committed to keeping laboratorians safe and protected during the testing process” > > Tweet this Thermo Fisher Scientific developed the InhibiSURE Viral Inactivation Medium formula to be non-hazardous.

• “As testing demands continue to change dynamically throughout this pandemic, we remain committed to keeping laboratorians safe and protected during the testing process,” said Duncan Porter, general manager, sample collection and transport for Thermo Fisher’s microbiology business.
• InhibiSURE Viral Inactivation Medium: Helps keep staff safe, inactivating SARS-CoV-2 within 30 minutes of sampling with a non-hazardous formula that does not contain any products that may react with bleach Provides a convenient, leakproof, format that can be used with unprocessed nasal swabs, nasopharyngeal swabs or throat swabs on automation preparation racks and decappers * Enhances simplicity by removing the need for de-activation steps, and is suitable for use with bead and column-based PCR systems InhibiSURE Viral Inactivation Medium is now commercially available from Thermo Fisher Scientific in Europe, with plans for launch in other regions pending relevant regulatory approvals.

Click To Read Full Article